… and response to temozolomide in 44 patients with pituitary carcinomas or aggressive
pituitary tumours reported in the literature. The results suggest that temozolomide should be …

… pituitary tumors or carcinomas treated with temozolomide … ) has been suggested to predict
resistance to temozolomide. … of temozolomide in patients with aggressive pituitary tumors or …

… treatment of surgery, … pituitary carcinoma treated with temozolomide. In June, 1997, a
72-year-old man with known microprolactinoma, successfully controlled with D2-agonist treatment (…

… We present three patients with pituitary tumours treated with TMZ. One tumour was
initially a macroprolactinoma that developed into a mixed GH- and prolactin-secreting …

… progressive pituitary adenoma or carcinoma. We report a survey study of Italian patients
treated with Temozolomide because of aggressive pituitary adenoma or carcinoma resistant to …

… treatment decisions. TMZ has an accepted role in treating pituitary carcinoma and adenomas
if radiation and surgery have failed to control tumour growth. To use TMZ on the basis of …

… Only few retrospective studies have reported an efficacy rate of temozolomide (TMZ) in
pituitary tumors (PT), all around 50%. However, the long-term survival of treated patients is rarely …

… To the best of our knowledge, to date 30 cases of pituitary adenoma have been treated with
temozolomide (7-16,1820,22-26,28,29). Patient ages varied from 20 to 71 years (mean: 51 …

… therapy or cytotoxic chemotherapy.We report two cases of pituitary carcinomas that
responded to temozolomide… associated with temozolomide treatment. If proven effective, this …

… with the use of temozolomide in six patients with different variants of aggressive pituitary
tumors. … We use the denomination pituitary carcinoma when extrapituitary presence of tumor (…